TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS RECEIVING CDK4/6 INHIBITORS FOR HR+/HER2ADVANCED/METASTATIC BREAST CANCER IN A SINGLE-CENTRE, CANADIAN REAL-WORLD SETTING USING AI-EXTRACTED DATA

被引：0
|
作者：
Moulson, Ruth [1 ]
Feugere, Guillaume [2 ]
Moreira-Lucas, Tracy [2 ]
Dequen, Florence [2 ]
Weiss, Jessica [1 ]
Smith, Janet [3 ]
Brezden-Masley, Christine [3 ]
机构：
[1] Pentavere, Toronto, ON, Canada
[2] Pfizer Canada, Kirkland, PQ, Canada
[3] Mt Sinai Hosp, New York, NY USA
来源：
BREAST | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO107
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns and clinical outcomes among women with HR+/HER2-advanced or metastatic breast cancer treated in real-world settings in Italy and Germany
    De laurentiis, Michelino
    Harbeck, Nadia
    Law, Ernest
    Ajmera, Mayank
    Mitra, Debanjali
    Davis, Keith
    Brucker, Sara
    De Placido, Sabino
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2-metastatic breast cancer
    Cuyun Carter, Gebra
    Sheffield, Kristin M.
    Gossai, Anala
    Huang, Yu-Jing
    Zhu, Yajun Emily
    Bowman, Lee
    Nash Smyth, Emily
    Mathur, Raina
    Cohen, Aaron B.
    Rasmussen, Erik
    Balakrishna, Shreya
    Morato Guimaraes, Claudia
    Rybowski, Sarah
    Seidman, Andrew D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1179 - 1187
  • [23] A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2-advanced breast cancer
    Sanchez-Bayona, Rodrigo
    Alva, Manuel
    de Sa, Alfonso Lopez
    Gilarranz, Yolanda Jerez
    de Torre, Ana Sanchez
    Tolosa, Pablo
    de Luna, Alicia
    Lopez-Tarruella, Sara
    Lema, Laura
    Moreno, Fernando
    Echavarria, Isabel
    Madariaga, Ainhoa
    Benitez, Javier
    Herrero, Blanca
    Rey, Macarena
    Ortega, Justo
    Gamez, Salvador
    Modrego, Andrea
    Lozano, Rocio Martin
    Figuero-Perez, Luis
    Jimenez, Roberto
    Sevilla, Marta Gonzalez
    Gonzalez, Irene
    Beranek, Marianela Bringas
    de Toro, Maria
    Massarrah, Tatiana
    del Monte-Millan, Maria
    Pinardo, Marina
    Manso, Luis
    Bueno-Muino, Coralia
    Garcia-Saenz, Jose Angel
    Martin, Miguel
    Ciruelos, Eva
    CANCER RESEARCH, 2023, 83 (05)
  • [24] Clinical outcomes of patients with HR+HER2-advanced breast cancer with early progression on CDK4/6 inhibitors
    Clifton, Katherine K.
    Thomas, Shana N.
    Luo, Jingqin
    Xi, Jing
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    Suresh, Rama
    Frith, Ashley
    Davis, Andrew A.
    Bose, Ron
    Weilbaecher, Katherine
    Hensing, Whitney L.
    Pluard, Timothy
    Cristofanilli, Massimo
    Han, Hyo S.
    Brufsky, Adam M.
    Kalinsky, Kevin
    Goel, Shom
    Wander, Seth A.
    Peterson, Lindsay L.
    Ma, Cynthia
    CANCER RESEARCH, 2023, 83 (05)
  • [25] The CDK4/6 inhibitors takeover of the HR+/HER2-locally advanced to metastatic breast cancer market in the EU5: Findings from a real-world study
    Graff, P-O.
    Jindal, K.
    Anger, C.
    Mendoza, L. A.
    Moehler, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S469 - S469
  • [26] Real-world treatment patterns and clinical outcomes in patients receiving palbociclib combinations for HR+/HER2- advanced/metastatic breast cancer in Japan: Results from the IRIS study
    Mycock, Katie
    Zhan, Lin
    Hart, Kieran
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
  • [27] Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in Real-World Setting in Taiwan
    Novick, Diego
    Rajan, Narayan
    Wei, Alice
    Cheng, Rebecca
    Colman, Sam
    Szende, Agota
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 36 : 98 - 104
  • [28] Real-world Treatment Patterns and Outcomes in HR+/HER2+Metastatic Breast Cancer Patients: A National Cancer Database Analysis
    Statler, Abby B.
    Hobbs, Brian P.
    Wei, Wei
    Gupta, Annie
    Blake, Cassann N.
    Nahleh, Zeina A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Real-world second-line treatment patterns and associated clinical outcomes for 2795 patients with advanced HR+HER2-breast cancer treated with first-line CDK4/6 inhibitors
    Clifton, Katherine K.
    Wander, Seth A.
    Ma, Cynthia
    Davis, Andrew A.
    Weipert, Caroline
    Zhang, Nicole
    Bucheit, Leslie
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis
    Abby B. Statler
    Brian P. Hobbs
    Wei Wei
    Annie Gupta
    Cassann N. Blake
    Zeina A. Nahleh
    Scientific Reports, 9
12345